Connective tissue disease related interstitial lung diseases and idiopathic pulmonary fibrosis: provisional core sets of domains and instruments for use in clinical trials

Idiopathic pulmonary fibrosis: is all-cause mortality a practical and realistic end-point for clinical trials?

(2013) Tamera Jo Corte et al.   THORAX

The UCSD shortness of breath questionnaire has longitudinal construct validity in idiopathic pulmonary fibrosis

(2012) Jeffrey J. Swigris et al.   RESPIRATORY MEDICINE

Hot of the breath: Mortality as a primary end-point in IPF treatment trials: the best is the enemy of the good

(2012) Athol U Wells et al.   THORAX

The development and validation of the King's Brief Interstitial Lung Disease (K-BILD) health status questionnaire

(2012) Amit S Patel et al.   THORAX

Interventions to improve symptoms and quality of life of patients with fibrotic interstitial lung disease: a systematic review of the literature

(2012) Sabrina Bajwah et al.   THORAX

Forced Vital Capacity in Patients with Idiopathic Pulmonary Fibrosis

(2011) Roland M. du Bois et al.   AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE

An Official ATS/ERS/JRS/ALAT Statement: Idiopathic Pulmonary Fibrosis: Evidence-based Guidelines for Diagnosis and Management

(2011) Ganesh Raghu et al.   AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE

Screening for interstitial lung disease in systemic sclerosis: the diagnostic accuracy of HRCT image series with high increment and reduced number of slices

(2011) Anna Winklehner et al.   ANNALS OF THE RHEUMATIC DISEASES

EUSTAR biobanking: recommendations for the collection, storage and distribution of biospecimens in scleroderma research

(2011) C. Beyer et al.   ANNALS OF THE RHEUMATIC DISEASES

Predicting treatment outcomes and responder subsets in scleroderma-related interstitial lung disease

(2011) Michael D. Roth et al.   ARTHRITIS AND RHEUMATISM

Dyspnea-12 Is a Valid and Reliable Measure of Breathlessness in Patients With Interstitial Lung Disease

(2011) Janelle Yorke et al.   CHEST

Correlation of Cough With Disease Activity and Treatment With Cyclophosphamide in Scleroderma Interstitial Lung Disease

(2011) Arthur C. Theodore et al.   CHEST

Clinical and radiographic correlates of hypoxemia and oxygen therapy in the COPDGene study

(2011) Deog Kyeom Kim et al.   RESPIRATORY MEDICINE

Cough predicts prognosis in idiopathic pulmonary fibrosis

(2011) CHRISTOPHER J. RYERSON et al.   RESPIROLOGY

Rheumatoid Arthritis–Interstitial Lung Disease–associated Mortality

(2010) Amy L. Olson et al.   AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE

Causes and risk factors for death in systemic sclerosis: a study from the EULAR Scleroderma Trials and Research (EUSTAR) database

(2010) A. J. Tyndall et al.   ANNALS OF THE RHEUMATIC DISEASES

A simple assessment of dyspnoea as a prognostic indicator in idiopathic pulmonary fibrosis

(2010) O. Nishiyama et al.   EUROPEAN RESPIRATORY JOURNAL

Assessing dyspnea and its impact on patients with connective tissue disease-related interstitial lung disease

(2010) Jeffrey J. Swigris et al.   RESPIRATORY MEDICINE

Development and validity testing of an IPF-specific version of the St George's Respiratory Questionnaire

(2010) J. Yorke et al.   THORAX

MRC chronic Dyspnea Scale: Relationships with cardiopulmonary exercise testing and 6-minute walk test in idiopathic pulmonary fibrosis patients: a prospective study

(2010) Effrosyni D Manali et al.   BMC Pulmonary Medicine

The SF-36 and SGRQ: Validity and first look at minimum important differences in IPF

(2009) Jeffrey J. Swigris et al.   RESPIRATORY MEDICINE

Interstitial Lung Disease in Systemic Sclerosis

(2008) Nicole S. L. Goh et al.   AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE

Patient-reported outcomes: Assessment and current perspectives of the guidelines of the Food and Drug Administration and the reflection paper of the European Medicines Agency

(2008) Andrew Bottomley et al.   EUROPEAN JOURNAL OF CANCER